Urinary excretion of prostacyclin and thromboxane A2 metabolites after angiotensin converting enzyme inhibition in hypertensive patients
- 1 June 1983
- journal article
- clinical trial
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 11 (2) , 143-150
- https://doi.org/10.1016/0262-1746(83)90014-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effects of enalapril, a new converting enzyme inhibitor, in hypertensionClinical Pharmacology & Therapeutics, 1982
- A Comparative Pilot Study of Enalapril, A New Converting Enzyme Inhibitor, and Hydrochlorothiazide in Essential HypertensionThe Journal of Clinical Pharmacology, 1982
- Low-Dose CaptoprilArchives of internal medicine (1960), 1982
- Effects of captopril on prostaglandin and natriuresis in patients with essential hypertensionThe American Journal of Cardiology, 1982
- Captopril: Clinical Pharmacology and Benefit‐to‐Risk Ratio in Hypertension and Congestive Heart FailurePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- Hormonal responses to long-term converting enzyme inhibition in hypertensive patientsClinical Pharmacology & Therapeutics, 1981
- Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captoprilAmerican Heart Journal, 1981
- Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.Hypertension, 1981
- Captopril-induced Changes in Prostaglandin ProductionJournal of Clinical Investigation, 1980
- Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endotheliumThrombosis Research, 1979